On the 18th, at a nursing center in Yangcheon-gu, Seoul, medical staff from a health center in Yangcheon-gu are subdividing prior to the AstraZeneca (AZ) vaccination visit to the center workers. yunhap news
The quarantine authorities said that they fall under the’Cautions’ for vaccination announced by the European Medicines Agency (EMA) in the 20 cases in which thrombosis was confirmed after receiving the AstraZeneca (AZ) novel coronavirus infection (Corona 19) vaccine.
Venous sinus thrombosis is a blood clotting disorder in which a blood clot occurs in the venous sinus, a large vein in the brain. EMA says that AstraZeneca vaccines are not associated with an increase in the overall risk of blood clots, but in rare cases it can cause thrombocytopenia or sinus thrombosis, so care should be taken by healthcare professionals. I have said that.
Health officials say there is no change in the AstraZeneca vaccination plan. “The European Medicines Safety Agency announced the evaluation result that there was no causality, and the World Health Organization (WHO) also recommended that the vaccination continue.” However, “In relation to thrombosis, we plan to organize and operate an expert advisory group to conduct an in-depth evaluation, and we will explain the detailed composition plan as soon as they are discussed,” said Park Young-joon, head of the adverse reaction investigation team.
Since the first vaccination of the Corona 19 vaccine, which started last month, reports of suspected adverse reactions have increased by 150 on the 19th, and a total of 9757 cases have been received so far. Among them, 9641 cases were common cases of muscle pain, headache and fever after vaccination, but 16 cases of death, suspected anaphylaxis (89 cases), and severe suspicious cases (11 cases) are being investigated.
Reporter Moon Hyun-kyung [email protected]
